Elder Pharmaceuticals is planning to expand its footprint in the Rs 4,000-crore dermatology segment in a big way. The company already has some presence in skin care category but with a slew of new launches, it plans to grab a market share of 4-5 per cent in each sub-category.
Meanwhile, the company has introduced ‘Eslite Plus’, a hydroquinone and combination cream for skin lightening; ‘Ultraguard’, a sunscreen containing American & European FDA standard ingredients; ‘B-New’, an anti-aging cream; ‘Camoflage’, a stretch-marks & pregnancy line remover and ‘Skin O2’, a multi vitamin product in soft gelatin capsules for skin nourishment.
Elder Pharmaceuticals has around six manufacturing units in India, all as per international standards. Post increasing its stake in Elder Biomeda AD and Neutrahealth PLC, EPL also has access to the manufacturing units of these companies in Bulgaria and Birmingham, UK respectively coupled with distribution network and brands of the same.
